3-Fluoro-4-nitrotoluene | CAS:446-34-4

We serve 3-Fluoro-4-nitrotoluene CAS:446-34-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Fluoro-4-nitrotoluene

Product Name: 3-Fluoro-4-nitrotoluene
Other Name: 2-Fluoro-4-methyl-nitrobenzene;1-Nitro-2-fluoro-4-methylbenzene;4-Methyl-2-fluoro-nitrobenzene
CAS No: 446-34-4
MF: C7H6FNO2
MW: 155.12600
Density: 1,438 g/cm3
Boiling point: 97-98 °C3 mm Hg(lit.)
Melting point: 52-55 °C(lit.)
Flash point: >230 °F
UN Number: UN2811
UN Proper Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Transport hazard class: 6.1
Packing group: III
 
Specification
Appearance: Off-white to pale yellow crystalline powder
Purity: ≥98%
Water: ≤0.5%
 
Application: Organic intermediates, pharmaceutical intermediates, agrochemical intermediates.
Package: 25kg/drum, packed in plastic drum or plastic coated iron drum.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 3-Fluoro-4-nitrotoluene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Methyl-2-fluoro-nitrobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Fluoro-4-methyl-nitrobenzene Use and application,3-Fluoro-4-nitrotoluene technical grade,usp/ep/jp grade.


Related News: Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.Methyl 2-iodobenzoate manufacturer Looking after their staff: Airlines are under pressure from their staff, who obviously want to protect themselves.L-Arginine supplier Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.Ethyl (E)-3,5-dihydroxy-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-hept-6-enoate vendor In terms of business, the industrial business increased by 7.97% year-on-year, while the revenue from the trading business shrank to a certain extent. The growth rate of industrial business was significantly slower than 24% in the first half of the year, showing that the growth rate of industrial business was lower in the third quarter, which was also the main reason for the decline in the company’s operating income in the third quarter. The company’s industrial business is mainly pesticide intermediates, accounting for about 85%. The scale of the pesticide intermediate business is large and the base is high, which is putting pressure on growth.The WHO says humans are mostly infected with MERS through direct or indirect contact with infected dromedary camels, and human-to-human transmission is rare.